Free tool
FAERS Monitor: Sterile Water
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017428 or its brand name (Sterile Water, Sterile Water For Irrigation). Reports on generic versions are filed under their own applications.
Reports
6,109
Serious
3,365
55% of reports
Hospitalization
1,796
Death reported
206
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hereditary angioedema609
- fatigue328
- nausea308
- headache297
- product dose omission issue291
- pyrexia270
- weight increased259
- pain256
- weight decreased253
- myelosuppression247
- vomiting235
- inappropriate schedule of product administration233
- dyspnoea218
- drug ineffective203
- off label use200
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 15 |
| 2005 | 20 |
| 2006 | 3 |
| 2007 | 11 |
| 2008 | 8 |
| 2009 | 12 |
| 2010 | 20 |
| 2011 | 16 |
| 2012 | 26 |
| 2013 | 42 |
| 2014 | 135 |
| 2015 | 333 |
| 2016 | 269 |
| 2017 | 213 |
| 2018 | 601 |
| 2019 | 382 |
| 2020 | 233 |
| 2021 | 368 |
| 2022 | 568 |
| 2023 | 570 |
| 2024 | 653 |
| 2025 | 773 |
| 2026 | 838 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,050 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hereditary angioedemaSignal | 609 | 207.1 | 191.6 | 117,677 |
| myelosuppressionSignal | 247 | 23.8 | 21.0 | 5,336 |
| inappropriate schedule of product administrationSignal | 233 | 4.5 | 3.9 | 626 |
| weight increasedSignal | 259 | 4.0 | 3.5 | 582 |
| product dose omission issueSignal | 291 | 3.4 | 3.0 | 500 |
| weight decreasedSignal | 253 | 3.1 | 2.8 | 367 |
| pyrexiaSignal | 270 | 2.7 | 2.4 | 289 |
| vomiting | 235 | 1.7 | 1.5 | 72 |
| headache | 297 | 1.6 | 1.5 | 74 |
| fatigue | 328 | 1.5 | 1.3 | 47 |
| pain | 256 | 1.4 | 1.3 | 34 |
| nausea | 308 | 1.3 | 1.2 | 27 |
| dyspnoea | 218 | 1.3 | 1.2 | 18 |
| off label use | 200 | 0.8 | 0.7 | 12 |
| drug ineffective | 203 | 0.5 | 0.5 | 90 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.